Clinical Trial Update: Improvement Effect of Lacosamide and Levetiracetam on Cognitive in Alzheimer's Disease Patients With Epilepsy [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the improvement in cognitive function with lacosamide and levetiracetam in patients with Alzheimer's disease and epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)
• Lacosamide (Lacosamide)

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Alzheimer Disease 3, Epilepsy | Phase 4 | Status: UNKNOWN